Literature DB >> 32214260

We need more evidence to answer questions about screening.

Laura Esserman.   

Abstract

Keywords:  Cancer; Health care; Medical research

Year:  2020        PMID： 32214260     DOI： 10.1038/d41586-020-00842-7

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades.

Authors:  Laura J Esserman; Christina Yau; Carlie K Thompson; Laura J van 't Veer; Alexander D Borowsky; Katherine A Hoadley; Nicholas P Tobin; Bo Nordenskjöld; Tommy Fornander; Olle Stål; Christopher C Benz; Linda S Lindström
Journal:  JAMA Oncol       Date:  2017-11-01       Impact factor: 31.777

Review 2.  The WISDOM Study: breaking the deadlock in the breast cancer screening debate.

Authors:  Laura J Esserman
Journal:  NPJ Breast Cancer       Date:  2017-09-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.